stocksINDOCO
INDOCO

Indoco Remedies Ltd.

226.50+0.9 (+0.40%)
23 Oct, 12:00 AM

Annual Reports and Financial Documents

Indoco Remedies Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

Corporate Announcements and Regulatory Filings

Indoco Remedies Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Analyst / Investor Meet21 Oct 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of Earnings Conference Call on Unaudited Financial Results for Quarter and Half year ended 30th September 2026
  2. Board Meeting14 Oct 2026
    Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
    Indoco Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2026 ,inter alia, to consider and approve A meeting of the Board of Directors ....
  3. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20187 Oct 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Attached the certificate issued by MUFG Intime India Private Ltd, Registrar and Transfer Agent of the Company, confirming compliance under Regulation 74(5) of SEBI(D & P) Regulations,2018 ....
  4. General29 Sept 2026
    Intimation To Shareholders Holding Shares In Physical Mode Regarding Mandatory Furnishing Of PAN, KYC And Bank Details As Per SEBI Master Circular No. HO/38/13/(4)2026-MIRSD-POD/I/4298/2026 Dated February 6, 2026
    Pursuant to Regulation 30 and Part A of Schedule III of SEBI (LODR) Regulations,2015, please find enclosed a copy of the letter dispatched to shareholders holding shares in physical mode, ....
  5. Acquisition28 Sept 2026
    Announcement under Regulation 30 (LODR)-Acquisition
    Pursuant to Regulation 30 of the SEBI (LODR) Regulations,2015, please note that the Company received intimation today that the Wholly Owned Subsidiary of the Company in the name and style ....
  6. Closure of Trading Window28 Sept 2026
    Closure of Trading Window
    Intimation regarding Closure of Trading Window
  7. General24 Sept 2026
    Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - ESG Rating
    Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,2015-ESG rating
  8. Acquisition18 Sept 2026
    Announcement under Regulation 30 (LODR)-Acquisition
    Pursuant to Regulation 30 of SEBI LODR, the Committee of Executive Directors in its meeting held today i.e. 18th September, 2026 has considered and approved the incorporation of the wholly ....
  9. AGM18 Sept 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    Please find enclosed herewith the details of Voting Results and Scrutinizers Report for the 79th AGM of the Company held on 17th September, 2026
  10. AGM17 Sept 2026
    Shareholder Meeting / Postal Ballot-Outcome of AGM
    We are submitting herewith the details regarding the Proceedings of the 79th AGM of the Company held on Thursday, 17th September, 2026 at 10.30 am through video conferencing(VC)/other audio ....
  11. General10 Sept 2026
    Disclosure Under Regulation 30 Of SEBI (LODR) Regulations,2015
    UK MHRA inspection at Company''s manufacturing facility at Plant I (solid oral dosage form) located at Goa.
  12. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201110 Sept 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditi M Panandikar & Others
  13. General5 Sept 2026
    Disclosure Under Regulation 30 Of SEBI (LODR) Regulations,2015
    USFDA inspection at Company''s manufacturing facility at Plant II (Sterile) located at Goa.
  14. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 20113 Sept 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditi Panandikar & Others
  15. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 20111 Sept 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditi M Panandikar & Others
  16. Memorandum of Understanding /Agreements27 Aug 2026
    Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
    Intimation of execution of Deed of Conveyance for Sale of Company''s plot of land.
  17. Newspaper Publication22 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Advertisement-Information regarding 79th Annual General meeting and E-voting
  18. Business Responsibility and Sustainability Reporting (BRSR)21 Aug 2026
    Business Responsibility and Sustainability Reporting (BRSR)
    Business Responsibility and Sustainability Reporting (BRSR)
  19. Reg. 34 (1) Annual Report21 Aug 2026
    Reg. 34 (1) Annual Report.
    Annual Report for the financial year 2025-2026
  20. AGM21 Aug 2026
    Notice Of 79Th Annual General Meeting And Annual Report For The Financial Year 2025-2026
    Notice of 79th Annual General Meeting and Annual Report for the Financial year 2025-2026

Frequently Asked Questions

Where can I download the annual report of Indoco Remedies Ltd.?
Annual reports of Indoco Remedies Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Indoco Remedies Ltd.?
Quarterly earnings results and presentations of Indoco Remedies Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Indoco Remedies Ltd. publish earnings call transcripts?
Earnings call transcripts of Indoco Remedies Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Indoco Remedies Ltd.?
Investor presentations and annual day presentations of Indoco Remedies Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Indoco Remedies Ltd.?
Corporate announcements and regulatory filings of Indoco Remedies Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Indoco Remedies Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Indoco Remedies Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Indoco Remedies Ltd.?
The ISIN (International Securities Identification Number) of Indoco Remedies Ltd. is INE873D01024. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Indoco Remedies Ltd. listed?
Indoco Remedies Ltd. is listed on NSE and BSE. The NSE symbol is INDOCO and the BSE code is -.
Where can I find the shareholding pattern of Indoco Remedies Ltd.?
The quarterly shareholding pattern of Indoco Remedies Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Indoco Remedies Ltd. on Sharpely?
Share price data for Indoco Remedies Ltd. is updated as of 23 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.